RBC Capital Maintains Outperform on Natera, Raises Price Target to $460

9/25/2026
Impact: 75
Healthcare

RBC Capital analyst Dan Leonard has maintained an Outperform rating on Natera (NASDAQ: NTRA) and raised the price target from $350 to $460. This adjustment reflects a positive outlook on the company's performance.

AI summary, not financial advice

Share: